Di Perri T, Laghi Pasini F, Pasqui A L, Ceccatelli L, Capecchi P L, Orrico A
Microcirc Endothelium Lymphatics. 1984 Aug;1(4):415-29.
Flunarizine, a calcium entry blocker drug, concentration-dependently inhibited FMLP and A23187-induced aggregation, enzyme release and superoxide anion generation from human granulocytes. A23187-dependent granulocyte aggregation was also studied in media devoided of Ca++ or Mg++. Flunarizine (2.4 x 10(-5) M) significantly affected not only Ca++-supported but also Mg++-sustained granulocyte aggregation. The inhibiting effect of the drug was reversed by increasing extracellular level of Ca++ (1.2 mM) or Mg++ (2 mM). In this "in vitro" model, the role of flunarizine as a specific Mg++ entry blocker was suggested.
氟桂利嗪是一种钙通道阻滞剂,能浓度依赖性地抑制人粒细胞由FMLP和A23187诱导的聚集、酶释放及超氧阴离子生成。还在不含Ca++或Mg++的培养基中研究了A23187依赖性粒细胞聚集。氟桂利嗪(2.4×10(-5)M)不仅显著影响Ca++支持的粒细胞聚集,也显著影响Mg++维持的粒细胞聚集。增加细胞外Ca++(1.2 mM)或Mg++(2 mM)水平可逆转该药的抑制作用。在这个“体外”模型中,提示了氟桂利嗪作为一种特异性Mg++通道阻滞剂的作用。